NRX Pharmaceuticals, Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

NRX Pharmaceuticals, Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. Announces Proposed Public Offering of Common Stock WILMINGTON, Del. , June 2, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc.